Haematologica (Feb 2023)
Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and <i>KIT</i> and/or <i>FLT3</i>- ITD mutations: results of the SAL MIDOKIT trial
- Leo Ruhnke,
- Christoph Röllig,
- Sylvia Herold,
- Tim Sauer,
- Christian H. Brandts,
- Björn Steffen,
- Kerstin Schäfer-Eckart,
- Stefan W. Krause,
- Mathias Hänel,
- Albrecht Reichle,
- Sebastian Scholl,
- Andreas Neubauer,
- Jan-Henrik Mikesch,
- Johannes Schetelig,
- Friedrich Stölzel,
- Michael Kramer,
- Annett Haake,
- Julia Frimmel,
- Alwin Krämer,
- Richard Schlenk,
- Uwe Platzbecker,
- Hubert Serve,
- Claudia D. Baldus,
- Carsten Müller-Tidow,
- Daniela Aust,
- Martin Bornhäuser,
- Gerhard Ehninger,
- Christian Thiede
Affiliations
- Leo Ruhnke
- Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden
- Christoph Röllig
- Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden
- Sylvia Herold
- Institute of Pathology, University Hospital Dresden, Dresden
- Tim Sauer
- Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg
- Christian H. Brandts
- Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt
- Björn Steffen
- Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt
- Kerstin Schäfer-Eckart
- Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg
- Stefan W. Krause
- Department of Internal Medicine V, University Hospital Erlangen, Erlangen
- Mathias Hänel
- Department of Internal Medicine III, Chemnitz Hospital, Chemnitz
- Albrecht Reichle
- Department of Internal Medicine III, Hematology and Internal Oncology, University Hospital Regensburg, Regensburg
- Sebastian Scholl
- Department of Internal Medicine II, Hematology and Internal Oncology, University Hospital Jena, Jena
- Andreas Neubauer
- Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg, Marburg
- Jan-Henrik Mikesch
- Department of Internal Medicine A, University Hospital Münster, Münster
- Johannes Schetelig
- Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany; DKMS Clinical Trials Unit, Dresden
- Friedrich Stölzel
- Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden
- Michael Kramer
- Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden
- Annett Haake
- Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden
- Julia Frimmel
- Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden
- Alwin Krämer
- Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg
- Richard Schlenk
- Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg
- Uwe Platzbecker
- Department of Internal Medicine I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig
- Hubert Serve
- Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt
- Claudia D. Baldus
- Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel
- Carsten Müller-Tidow
- Department of Internal Medicine V, University of Heidelberg, Heidelberg
- Daniela Aust
- Institute of Pathology, University Hospital Dresden, Dresden
- Martin Bornhäuser
- Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany; German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT) Dresden, Dresden
- Gerhard Ehninger
- Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden
- Christian Thiede
- Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany; Agendix GmbH, Dresden
- DOI
- https://doi.org/10.3324/haematol.2022.281636
- Journal volume & issue
-
Vol. 108,
no. 9
Abstract
No abstracts available.
